Login to Your Account



Acucela Getting $5M Up Front from Otsuka for Vision Drug

By Catherine Hollingsworth


Monday, September 8, 2008
Acucela Inc. said it will receive $5 million up front and up to $258 million in milestone payments in a deal with Japan's Otsuka Pharmaceutical Co. Ltd. to co-develop the U.S. biotech's product for vision loss. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription